CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
Author
Andrew Pennell
Bekker
+19Â more
Bin N. Zhao
Daniel J. Dairaghi
Emily Wendt
J. J. Kim Wright
Juan C. Jaen
Keshav
Linda S. Ertl
Mark E. T. Penfold
Matthew J. Walters
Nu Lai
Parronchi
Pirow Bekker
Satish Keshav
Solomon Ungashe
Thomas J. Schall
Trageen Baumgart
Yu Wang
Zaballos
Zheng Wei
Publication venue
'American Society for Pharmacology & Experimental Therapeutics (ASPET)'
Publication date
Field of study
Full text link
Crossref
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice
Author
Andrew Pennell
Antoni Krasinski
+19Â more
Basak A
Bin N. Zhao
Chia-Lin Tsou
Daniel J. Dairaghi
Israel Charo
Jay Powers
Juan C. Jaen
Landin Boring
Linda S. Ertl
Lisa Seitz
Robert D. Berahovich
Ruiping Zhao
Solomon Ungashe
Thomas J. Schall
Timothy Sullivan
Trageen Baumgart
Yu Wang
Zheng Wei
Zhenhua Miao
Publication venue
'American Physiological Society'
Publication date
Field of study
No full text
Crossref